(Q44915690)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Paolo Bernasconi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Orlandi E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alessandrino EP

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Iacona I

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Brusamolino E

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Bonfichi M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Calatroni S

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tenore A

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Montanari F

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Troletti D

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Pascutto C

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Regazzi M

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lazzarino M

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 July 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

175-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704551

29 December 2019

exact match

0 references

cites work

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

7 January 2021

Comparative Preclinical Study of Three Bone Marrow Purging Methods Using PCR Evaluation of Residual t(14;18) Lymphoma Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

7 January 2021

Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

7 January 2021

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

7 January 2021

Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

7 January 2021

Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

7 January 2021

The CD19+ B-cell counts at peripheral blood stem cell mobilization determine different levels of tumour contamination and autograft purgability in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704551

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704551

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15170171%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference